1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Search for AL amyloidosis risk factors using Mendelian randomization
(
- Contribution to journal › Article
- 2019
-
Mark
Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance
(
- Contribution to journal › Letter
- 2018
-
Mark
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma : Results from the collaboration to collect autologous transplant outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT chronic malignancies working party
(
- Contribution to journal › Article
-
Mark
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
(
- Contribution to journal › Article
- 2017
-
Mark
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts
(
- Contribution to journal › Letter